InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (5 ops.)
Browse the full record of transactions filed by ASELAGE STEVE, Director. Officer active across 3 companies, notably Travere Therapeutics, Inc.. In total, 24 disclosures have been logged. Total volume traded: €1.8m. The latest transaction was filed on 7 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations24 total
012,866 shares0
Common Stock
SEC:0001127602-22-017138:0·
€4,935569 shares@ €8.67330.0003% mcap11.4% of flow
Common Stock
SEC:0001127602-22-016409:0·
€53,7042,575 shares@ €20.85610.0014% mcap1.4% of flow
Common Stock
SEC:0001209191-22-028702:0·
€4,472301 shares@ €14.85550.0003% mcap10.4% of flow
Common Stock
SEC:0001127602-22-007717:0·
€3,8202,016 shares@ €1.895100.0% of flow
Common Stock
SEC:0001209191-21-069227·
Ideal exit: 5 Sept 2022 (T+270)
€3,8202,016 shares@ €1.89550.0% of flow
Common Stock
SEC:0001209191-21-069227:0·
Ideal exit: 5 Sept 2022 (T+270)
€4,421414 shares@ €10.67880.0003% mcap26.2% of flow
Common Stock
SEC:0001127602-21-030063·
€4,421414 shares@ €10.67880.0003% mcap10.3% of flow
Common Stock
SEC:0001127602-21-030063:0·
€822,24431,800 shares@ €25.85670.021% mcap44.7% of flow
Common Stock
SEC:0001209191-21-065439·
€822,24431,800 shares@ €25.85670.021% mcap22.0% of flow
Common Stock
SEC:0001209191-21-065439:0·
€140,45410,000 shares@ €14.04540.0035% mcap7.6% of flow
Common Stock
SEC:0001209191-21-063591·
€140,45410,000 shares@ €14.04540.0035% mcap3.8% of flow
Common Stock
SEC:0001209191-21-063591:0·
025,000 shares0
Common Stock
SEC:0001209191-21-062670·
025,000 shares0
Common Stock
SEC:0001209191-21-062670:0·
€842,40560,000 shares@ €14.04010.021% mcap45.8% of flow
Common Stock
SEC:0001209191-21-060035·
€842,40560,000 shares@ €14.04010.021% mcap22.6% of flow
Common Stock
SEC:0001209191-21-060035:0·
€4,233314 shares@ €13.47980.0003% mcap25.1% of flow
Common Stock
SEC:0001127602-21-024772·
€4,233314 shares@ €13.47980.0003% mcap9.8% of flow
Common Stock
SEC:0001127602-21-024772:0·
€8,200634 shares@ €12.93350.0005% mcap48.7% of flow
Common Stock
SEC:0001127602-21-018470·
€8,200634 shares@ €12.93350.0005% mcap19.0% of flow
Common Stock
SEC:0001127602-21-018470:0·
03,000 shares0
Common Stock
SEC:0001209191-21-033851·
03,000 shares0
Common Stock
SEC:0001209191-21-033851:0·
€34,6022,146 shares@ €16.12420.0009% mcap1.9% of flow
Common Stock
SEC:0001209191-21-032312·
€34,6022,146 shares@ €16.12420.0009% mcap0.9% of flow
Common Stock
SEC:0001209191-21-032312:0·
24 of 24 declarations
About ASELAGE STEVE
ASELAGE STEVE is an executive at Travere Therapeutics, Inc.
